Skip to main content
HR 8467 116th Congress House

Access to Rare Indications Act of 2020

Official title: To amend titles XVIII and XIX of the Social Security Act and title XXVII of the Public Health Service Act to provide for coverage of certain drugs used in the … Show full official titleShow less

Official title: To amend titles XVIII and XIX of the Social Security Act and title XXVII of the Public Health Service Act to provide for coverage of certain drugs used in the treatment or management of a rare disease or condition, and for other purposes.

Introduced: September 30, 2020 Introduced by: Thompson, Mike Democratic · California See on congress.gov
Health Drug therapyEmployee benefits and pensionsHealth care costs and insuranceHealth care coverage and access
More subjectsShow fewer subjects
Insurance industry and regulationMedicaidMedicarePrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 30, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 30, 2020
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action September 30, 2020

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

 Plain-English summary Congressional Research Service

Access to Rare Indications Act of 2020

This bill prohibits coverage exclusions or limitations under the Medicare prescription drug benefit, Medicaid, or private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals and that are supported by the National Institutes of Health Rare Diseases Clinical Research Network).

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Republican 1
R
Kelly, Mike
Pennsylvania · Sep 30, 2020
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 8467: Access to Rare Indications Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-HR-8467/
MLA
"H.R. 8467: Access to Rare Indications Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-8467/.
Bluebook (legal)
H.R. 8467, 116th Cong. (2026), https://openamerica.io/bill/116-HR-8467/.
Markdown link
[H.R. 8467: Access to Rare Indications Act of 2020](https://openamerica.io/bill/116-HR-8467/)
Report a problem